The wyss institute has developed an implantable vaccine that aims at preventing/ controling cancer related cases.

The vaccine that measures approximately 2mm x 8mm (size of a finger nail), is made up of a porous, spongy FDA approved polymer.

Unlike most therapeutic cancer vaccines available today which require doctors to first remove the patient’s immune cells the reprogram and introduce them back to the body.

This new vaccine is implanted under the skin near the lymph node and is designed to recruit and reprogram the patient’s own immune cells , “on-site”, instructing them to travel through the body, home in on cancer cells then kill them.

Apart from therapeutic applications, this technology can also be used to diagnose auto-immune diseases.
The chip was developed in collaboration with biologists, clinicians and researchers at the Institute, the Dana-Farber Cancer Institute and Harvard’s School of Engineering and Applied Sciences,